Bibliography
Adams, R. D., Denny-Brown, D. &Pearson, C.: Diseases of Muscle. New York, Hoeber, 1953.
Allan, W.: Dermatomyositis or Scleroderma; Report of a Case. Arch. Derm. Syph.19 265–269, 1929.
Anderson, H. J., Churchil-Davidson, H. C. &Richardson, A. T.: Bronchial neoplasma with myasthenia: prolonged apnoe after administration of succinylcholine. Lancet2 1291–1293, 1953.
Arkin, A.: A Clinical and pathological study of periarteritis nodosa: a report of five cases, on histologically healed. Amer. J. Path.6 401–426, 1930.
Arundel, F. D., Wilkinson, R. D. &Haserick, J. R.: Dermatomyositis and malignant neoplasms in adults. Arch. Derm.82 772–775, 1960.
Bezecny, G. M.: Dermatomyositis. Dtsch. Arch. Derm. Syph.171 242–251, 1935.
Bickerstaff, E. R. &Woolf, A. L.: The intramuscular nerve endings in myasthenia gravis. Brain83 10–23, 1960.
van Bogaert, L. &Radermecker, M. A.: De quelques affections musculaires primitives en dehors des myopathies. Etudes présentées à la lre Réunion Neurologique Belgo-Suisse; Edition des Acta neurol. psych. belg.,1, 1954.
Bouttier, M. &Bertrand, I.: Etude anatomo-clinique d'un cas de maysthénie Erb-Goldflam. Ann. Méd.10 173–184, 1921.
Buzzard, E. F.: The clinical cases and postmortem examination of five cases of myasthenia gravis. Brain28 438–483, 1905.
Coers, C. &Desmedt, J. E.: Abnormal end-plates in myasthenic muscle. Lancet2 1124, 1958.
Curtis, A. C., Blaylock, H. C. &Harrell, E. R.: Malignant lesions associated with dermatomyositis. J. A. M. A.150 844–846, 1952.
Dowling, G. B.: Scleroderma and dermatomyositis. Brit. J. Derm.67 275–290, 1955.
Gullberg, E.: Some observations indicating the possibility of a relation of the bacillus Koch to a yeast-like fungus (of oidium type). Acta med. scand.94 527–566, 1938.
Harbitz, F.: Periarteritis nodosa. Bull. N. Y. Acad. Med.3 17–18, 1927.
Heathfield, K. W. G. &Williams, J. R. B.: Peripheral neuropathy and myopathy associated with bronchogenic carcinoma. Brain77 122–137, 1954.
Hecht, M. S.: Dermatomyositis in childhood. J. Pediatr.17 791–800, 1940.
Henson, R. A., Russel, D. S. &Wilkinson, M.: Carcinomatous myopathy and myopathy. A clinical and pathological study. Brain77 82–121, 1954.
Hollstrom, Einar.: An investigation into a yeast-like fungus isolated from patients suffering from, or suspected of, pulmonary tuberculosis. Uppsala: Almqvist and Wiksells Boktryckeri A.–B. 107 pages.
Hueper, W. C.: Macromolecular substances as pathogenic agents. Arch. Path.33 267–290, 1942.
Kampmeier, R. H. &Shapiro, J. L.: Diffuse and sometimes recurrent course of diffuse arteritis; observation and report of a patient observed for twenty-one years. AMA Arch. intern. Med.92 856–879, 1953.
Klingman, W. O.: Dermatomyositis resulting in scleroderma. Arch. Neurol. Psych.24: 1187–1198, 1930.
Lewis, T.: Notes on scleroderma (dermatomyositis). Brit. J. Derm. Syph.52 233–242, 1940.
Mankiewicz, E., Stackiewicz, E. &Litwak, M.: A Polysaccharide isolated fromCandida albicans as growth promoting factor for myobacterium tuberculosis. Canad. J. Microbiol.5 261–267, 1958.
Mankowski, Z. T. &Littleton, B. J.: Action of cortisone and ACTH on experimental fungus infections. Antibiot. Chemother., N. Y.4 253–258, 1954.
Mankowski, Z. T.: The influence of various sex hormones on experimental fungus infections. Antiobiot. Chemother., N. Y.4 1101–1104, 1954.
Mankowski, Z. T.: The influence of hormonal conditions on experimental fungus infection. In Sternber, T., and Newcomer, V.: Therapy of fungus diseases. Little Brown, Boston and Toronto, 90–99, 1955.
Mankowski, Z. T.: The experimental pathogenicity of various species ofCandida in Swiss mice. Trans. N. Y. Acad. Sci.19 548–570, 1957.
Mankowski, Z. T.: The pathological activity of metabolic products ofCandida albicans on newborn mice. Mycopathol. et Mycol. Appl.17 165–175, 1962.
Mankowski, Z. T.: Occurrence of calcinosis in the course of experimental fungus infections. Sabouraudia,1 234–236, 1962.
Mankowski, Z. T.: Pathological changes observed during experimentalCandidiasis. Ninth Int. Congr. Bot., Montreal, 1959 p. 250.
McComb &MacMahon, H. E.: Dermatomyositis associated with metastazing bronchogenic carcinoma; a clinicopathological conference. Med. Clin. N. Amer.31 1148–1162, 1947.
McDermot, Violet: The changes in the motor end-plate in myasthenia gravis. Brain83 24–36, 1960.
Mackenzie, I.: Bronchial neoplasma with myasthenia gravis. Lancet1 108–109, 1954.
Mella, H.: Irradiation of the thymus in myasthenia gravis. Med. Clin. N. Amer.7 939–943, 1923.
Mendelow, H. &Genkins, G.: Studies in myasthenia gravis: cardiac and associated pathology. J. Mt. Sinai Hosp.21 218–225, 1954.
Nattras, F. J.: Discussion on polymyositis: clinical aspects. Proc. R. Soc. Med. Med.49 105–114, 1956.
Nixon, J. A.: Scleroderma and myositis. Lancet1 79–81, 1907.
O'Leary, P. A. &Waisman, M. D.: A study of forty cases. Arch. Derm. Syph.41 1001–1019, 1940.
Pagel, W., Woolf, A. L. &Osher, R.: Histological observation on dermatomyositis. J. Path. Bact.61 403–411, 1949.
Pearson, C. M. &Rose, A. S.: Myositis. Neuromuscular disorders. Res. Publ. Assoc. Nerv. Ment. Dis.XXXVIII, 422–478, 1961.
Ragan, C.: The effect of adrenotropic hormone (ACTH) (Armour) on the clinical syndrome of dermatomyositis. Proc. First Clinical ACTH conference, Philadelphia, The Blakistone Company, p. 423, 1950.
Rake, G.: On the pathology and pathogenesis of scleroderma. John. Hopkins Hosp. Bull.48 212–227, 1931.
Rantz, L. A., DiCapio, J. M. &Randall, E.: Antistreptolysin-O and antihyaluronidase titers in health and various diseases. Amer. J. med. Sos.224 194–200, 1952.
Reenstierna, J.: Sur la vie non acido-résistante des microorganisms de la tuberculose. Arch. Inst. Pasteur Tunis.15 309–317, 1926.
Rich, A. R.: The role of hypersensitivity in periarteritis nodosa as indicated by seven cases developing during serum sickness and sulfonamide therapy. Bull. Johns Hopkins Hosp.71 123–135, 1942.
Rich, A. R. &Gregory, J. E.: The experimental demonstration that periarteritis nodosa is a manifestation of hypersensitivity. Bull. Johns Hopkins Hosp.72 65–88, 1943.
Rothstein, J. L. &Welt, S. Calcinosis universalis and calcinosis circumscripta in infancy and in childhood. Amer. J. Dis. Child.52 368–422, 1936.
Rottino, Antonio: Myocardial lesions in myasthenia gravis. Arch. Path.34 557–561, 1942.
Rozenthal, C. &Hoffmann, H.: Ein Fall von Dermatomyositis mit Ausgang in Sklerodermie. Klin. Wschr.3 115–116, 1924.
Russell, D. S.: Histological changes in the striped muscles in myasthenia gravis. J. Path. Bact.65 279–289, 1953.
Shilo: Nonspecific resistance to infections. Ann. Rev. Microbiol.13 225–278, 1959.
Talbott, J. H., Gall, E. A., Consolazio, W. V. &Coombs, F. S.: Dermatomyositis with scleroderma, calcinosis and renal endarteritis associated with focal cortical necrosis. Arch. intem. Med.63 476–496, 1939.
Walker, R. P.: Congenital myasthenia gravis. Amer. J. Dis. Child.86 198–200, 1953.
Walton, J. N., andAdams, R. D.: Polymyositis. E. & S. Livingstone, Ltd. Edinburgh and London, 1958.
Weigert, C.: Pathologisch-anatomischer Beitrag zur Erbschen Krankheit. Neurol. Cblt.20 597–601, 1901.
Unverricht: Polymyositis acuta progressiva. Z. klin. Med.12 533–549, 1887.
Author information
Authors and Affiliations
Additional information
This paper was presented under the title “Chronic pathogenicity ofCandida albicans” at the Annual Meeting of American Mycological Society on August 28, 1961 at Lafayette, Indiana.
Rights and permissions
About this article
Cite this article
Mankowski, Z.T. Occurrence of malignancy, collagen diseases and myasthenia gravis in the course of experimental infections with Candida albicans. Mycopathologia et Mycologia Applicata 19, 1–20 (1963). https://doi.org/10.1007/BF02049009
Issue Date:
DOI: https://doi.org/10.1007/BF02049009